NASDAQ:INCY - Incyte Corporation
$83.57
 $0.15
+0.18%
1:45PM EDT
2019-02-15
Incyte Corporation, incorporated on April 8, 1991, is a biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutics. The Company's portfolio includes compounds in various stages, ranging from preclinical to late-stage development, and commercialized products, such as JAKAFI (ruxolitinib) and ICLUSIG (ponatinib). The Company has initiated REACH1, a pivotal Phase II trial in steroid-refractory acute graft-versus-host-disease (GVHD) and the first in a registration program for ruxolitinib in GVHD. A proof-of-concept trial of itacitinib, a selective janus associated kinases 1 (JAK1) inhibitor, is ongoing for the treatment of patients with acute GVHD.The Company has a portfolio of selective JAK1 inhibitors, including itacitinib and INCB52793. INCB52793 is in a Phase I/II trial in patients with advanced malignancies. INCB54828 is an inhibitor of the Fibroblast Growth Factor Receptor (FGFR) isoforms 1, 2 and 3. The Company is studying its bromodomain (BRD) inhibitors, INCB54329 and INCB57643, in open-label dose-escalation trials in patients with advanced malignancies. INCB53914 is a pan-PIM kinase inhibitor. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  INCY     avg for
industry  
  avg for
sector  
42 stocks weight:  46. 01   0. 00   0. 00  
42 stocks rank:  2. 86 K 1. 86 K 1. 09 K
# analyst opinions:  16. 00   14. 92   14. 43  
mean recommendation:  2. 00   1. 91   1. 93  

quick ratio:  3. 84   5. 37   1. 81  
current ratio:  4. 03   5. 69   2. 19  

target price low:  74. 00   88. 97   117. 82  
target price avg:  85. 63   115. 19   141. 96  
target price high:  111. 00   143. 40   163. 16  
1-yr high:  94. 63   124. 30   142. 77  
last close:  83. 42   101. 85   127. 84  
50-day avg:  72. 46   98. 27   122. 46  
200-day avg:  68. 68   99. 72   122. 70  
1-yr low:  58. 50   78. 19   100. 16  
volume:  994. 30 K 2. 38 M 4. 64 M
50-day avg volume:  1. 62 M 3. 31 M 4. 94 M
200-day avg volume:  1. 65 M 3. 23 M 4. 28 M

1-day return:  2. 91 % 0. 22 % 0. 48 %
this week return:  3. 15 % 1. 77 % 2. 01 %
12-wk return:  28. 99 % 6. 56 % 3. 33 %
52-wk return:  -8. 79 % -2. 23 % 14. 35 %

enterprise value (EV):  15. 86 B 55. 17 B 104. 51 B
market cap:  17. 75 B 49. 01 B 96. 46 B
EBITDA:  -5. 01 M 4. 82 B 7. 18 B
enterprise multiple (EV/EBITDA):  -3. 17 K -91. 79   2. 29  
enterprise/revenue (EV/R):  8. 82   29. 84   23. 39  
total revenue:  1. 80 B 11. 28 B 40. 22 B
total debt:  24. 87 M 13. 73 B 16. 57 B
debt/equity:  1. 38   258. 01   110. 73  
net income (common):  -109. 20 M 2. 37 B 3. 58 B

shares outstanding:  212. 81 M 607. 99 M 1. 22 B
shares:  177. 36 M 605. 53 M 1. 15 B
shares short:  5. 14 M 11. 62 M 12. 55 M
shares short prior month:  4. 92 M 11. 95 M 13. 44 M
short ratio:  2. 72   4. 82   3. 10  
short % of float:  3. 61 % 6. 19 % 2. 82 %
total cash/share:  6. 46   12. 02   11. 46  
total cash:  1. 38 B 7. 41 B 7. 37 B
free cash flow:  120. 92 M 95. 99 M 2. 04 B
operating cash flow:  163. 12 M 164. 74 M 3. 04 B

book value:  8. 47   14. 43   28. 26  
price/book:  9. 84   -1. 57   -2. 97  
gross profits:  142. 38 M 8. 28 B 18. 09 B
operating margins:  -3. 19 % -458. 01 % -642. 83 %
EBITDA margins:  -0. 28 % 13. 81 % 22. 47 %
profit margins:  -6. 07 % 6. 57 % 9. 92 %
gross margins:  20. 40 % 49. 33 % 54. 53 %

1-yr max volatility:  -22. 93 % --- ---
1-yr mean volatility:  0. 02 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 52   3. 03   4. 09  
forward EPS:  2. 05   4. 33   6. 99  
P/E:  -161. 98   6. 11   26. 91  
forward P/E:  39. 45   8. 38   10. 48  
PE/G:  -18. 73   0. 37   5. 61  
growth:  8. 65 % 683. 72 % 104. 79 %
earnings high:  0. 61   1. 27   1. 66  
earnings avg:  0. 46   1. 01   1. 53  
earnings low:  0. 20   0. 76   1. 40  
revenue high:  524. 92 M 2. 86 B 11. 19 B
revenue avg:  488. 31 M 2. 78 B 10. 84 B
revenue low:  460. 10 M 2. 67 B 10. 64 B
earnings growth:  -19. 30 % 150. 88 % 34. 85 %
1-qtr earnings growth:  -19. 10 % 151. 88 % 33. 25 %
return on assets:  -1. 47 % -3. 27 % 3. 81 %
return on equity:  -6. 13 % 107. 48 % 27. 82 %
revenue growth:  17. 90 % 648. 36 % 97. 70 %
revenue/share:  8. 48   14. 68   59. 83  

beta (1yr vs S&P500):  1. 42   1. 21   0. 93  
sharpe (1yr):  0. 10   0. 06   0. 98  

held % insiders:  0. 48 % 6. 46 % 3. 21 %
held % institutions:  94. 25 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : INCY
.    + 8.618 =         8.618 :: INITIAL WEIGHT
.   + 97.683 =       106.302 :: inverse volume-to-price addition
.  + 257.118 =        363.42 :: spline projection addition
.  + 842.742 =      1206.162 :: notable performance addition
.   - 91.141 =      1115.021 :: poor performance penalty
.    x 0.968 =      1078.933 :: one-year gains+dividend factor
.      x 7.5 =      8091.729 :: 13 weeks' performance factor
.    x 1.492 =     12076.815 :: industry recommendation factor
.    x 2.303 =     27815.729 :: symbol recommendation factor
.    x 1.296 =     36040.382 :: EV/R factor
.    x 0.998 =     35970.824 :: earnings growth factor
.      x 1.0 =      35965.55 :: return on assets factor
.    x 0.999 =     35943.489 :: return on equity factor
.    x 2.211 =     79460.594 :: revenue growth factor
.    x 2.707 =    215094.933 :: current ratio factor
.    x 1.163 =    250090.286 :: quick ratio factor
.    x 1.169 =    292471.695 :: short ratio factor
.    x 2.204 =    644597.604 :: price-to-book factor
.    x 1.003 =    646317.906 :: debt-to-equity factor
.    x 1.185 =    765977.963 :: 5-day avg > 200-day avg
.    x 1.123 =    860351.051 :: 5-day avg > 50-day avg
.    x 1.055 =    907792.025 :: 50-day avg > 200-day avg
.    x 1.021 =    926659.586 :: P/E weight
.    x 0.481 =    445459.792 :: PE/G factor
.    x 1.738 =    774311.445 :: beta factor
.      x 0.1 =     77176.356 :: sharpe factor
.    x 0.966 =     74582.925 :: target low factor
.    x 1.054 =     78629.422 :: target mean factor
.    x 1.057 =     83150.554 :: target high factor
.    x 1.066 =     88606.295 :: industry 12-weeks return
.    x 0.994 =     88050.791 :: "drift" penalty 5 days ago
.    x 0.998 =     87885.895 :: overall "drift" factor
.    x 0.999 =     87802.266 :: largest single-day jump factor
.     x 1.01 =     88680.138 :: mean volatility factor
.    x 1.098 =     97365.973 :: 42-day mean volatility factor
.      x 1.0 =     97372.508 :: factor hist industry gain for week 06
.   cubeRoot =        46.006 :: reduced for readability
.                     46.006 :: FINAL WEIGHT for NASDAQ:INCY


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org